A substantial advancement in glucose management is emerging with the release of tirzepatide at a dosage of 45mg. This updated formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, https://madesocials.com/story6856997/significant-approach-tirzepatide-dose-for-diabetes-control